REFERENCES
- Clayton Y.M. SF 86–327: A laboratory evaluation of 5 antifungal agents. Proceedings, 13th International Congress of Chemotherapy, K.H. Spitzy, K. Karrer. Verlag H. Igermann, Vienna 1983; 116/13–116/14, In
- Georgopoulos A., Petranyi G., Mieth H., Drews J. In vitro activity of naftifine, a new antifungal agent. Antimicrobial Agents and Chemotherapy 1981; 19: 386–389
- Meingassner J.G., Muller M., Sleytr U.B. SF 86–327: Effects on the ultrastructure of Candida albicans in vitro. Proceedings, 13th International Congress of Chemotherapy, K.H. Spitzy, K. Karrer. Verlag H. Igermann, Vienna 1983; 116/29–116/32, In
- Petranyi G., Meingassner J.G., Mieth H. SF 86–327: A new antimycotic agent and its antifungal activity in vitro. Proceedings, 13th International Congress of Chemotherapy, K.H. Spitzy, K. Karrer. Verlag H. Igermann, Vienna 1983; 116/9–116/12, In
- Petranyi G., Meingassner J.G., Mieth H. SF 86–327: a new antimycotic agent and its activity in laboratory animals. Proceedings, 13th International Congress of Chemotherapy, K.H. Spitzy, K. Karrer. Verlag H. Igermann, Vienna 1983; 116/15–116/19, In
- Petranyi G., Ryder N.S., Stutz A. Allylamine derivatives: New class of synthetic antifungal agents inhibiting fungal squalene epoxidase. Science 1984; 224: 1239–1241
- Ryder N.S., Troke P.F. The activity of naftifine as a sterol synthesis inhibitor in Candida albicans. Current Chemotherapy and Immunotherapy, P. Periti, G.G. Grassi. American Society for Microbiology, Washington, D.C. 1982; 2: 1016–1017, In
- Ryder N.S. SF 86–327: Studies on the antifungal mode of action. Proceedings, 13th International Congress of Chemotherapy, K.H. Spitzy, K. Karrer. Verlag H. Igermann, Vienna 1983; 116/20–116/24, In
- Shadomy S., Espinel-Ingroff A. Susceptibility testing with antifungal agents. Manual of Clinical Microbiology3rd edn, E.H. Lennette, A. Balows, Wm.J. Hausler, Jr., J.P. Truant, 1980; 647–653, In
- Shadomy S., Espinel-Ingroff A., Kerkering T.M. In vitro studies with four new antifungal agents: BAY n 7133, Bifonazole (BAY h 4502), ICI 153,066 and Ro 14-4767/002. Saoburaudia 1984; 22: 7–16
- Stutz A., Petranyi G. SF 86–327 and related allylamine derivatives with enhanced oral activity. Proceedings, 13th International Congress of Chemotherapy, K.H. Spitzy, K. Karrer. Verlag H. Igermann, Vienna 1983; 116/1–116/4, In